Quotient Sciences
Generated by Meeveem AI
"Accelerates drug development from molecule selection to commercial supply"
About Quotient Sciences
Quotient Sciences is a drug development and manufacturing organisation headquartered in Nottingham, with origins in 1990. It supports pharmaceutical and biotechnology companies developing small-molecule and synthetic peptide medicines, from early development and first-in-human studies through formulation development and commercial product supply. Its facilities combine clinical pharmacology, pharmaceutical development and manufacturing capabilities in the UK and USA.
Its Translational Pharmaceutics platform integrates formulation development, real-time drug product manufacturing and clinical testing within one programme. Teams use emerging clinical data to adjust formulations and guide development decisions. The platform brings work together under a single project manager, reducing the handovers between separate development suppliers.
A network of specialist teams
The group’s Edinburgh team analyses and reports clinical trial data, while its Nottingham and Miami clinics conduct early clinical studies. Manufacturing teams in the Philadelphia area support both early development and scale-up to commercial supply. Arcinova brings together the Alnwick and Reading operations for early drug development.
1300
Team Members
1990
Founded
Contract Research
Sector
On-Site
Work Environment